.
The drug was given either orally or through an IV. It reduced deaths by 35 per cent in patients who needed treatment with breathing machines and by 20 per cent in those only needing supplemental oxygen. It did not appear to help less ill patients. The study enrolled more than 11,000 patients in England, Scotland, Wales and Northern Ireland who were given either standard of care or that plus one of several treatments: the HIV combo drug lopinavir-ritonavir, the antibiotic azithromycin; the steroid dexamethasone, the anti-inflammatory drug tocilizumab, or plasma from people who have recovered from COVID-19 that contains antibodies to fight the virus.
Great news! I hope the worlds' doctors and hospitals implement these drugs and even hear about them. There is hope!
Have they carried out a series of experiments or is this just heresay?
Good old Dex!